The effectiveness of clove oil as a topical anesthetic in reducing pain during needle insertion
ISRCTN | ISRCTN10078508 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN10078508 |
Secondary identifying numbers | Funder No. 501100020595 |
- Submission date
- 18/10/2023
- Registration date
- 18/10/2023
- Last edited
- 10/11/2023
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Oral Health
Plain English summary of protocol
Background and study aims
Dental procedures can be distressing for children, often attributed to the pain experienced during an inferior alveolar nerve block (IANB), a common local anesthesia technique. This study endeavors to address this issue by comparing the efficacy of two analgesic agents: clove oil and 20% benzocaine gel.
Clove oil, derived from the clove plant, has shown promise as a natural analgesic with potential benefits in dentistry. Benzocaine gel, a synthetic local anesthetic, is a conventional choice for pain management during IANB. However, the comparative effectiveness of these two agents in pediatric patients remains largely unexplored.
Who can participate?
Children aged 7-11 years requiring non-urgent dental treatment under IANB.
What does the study involve?
Children were divided into two groups, with an equal number of kids in each group. This study was "double-blind," meaning that both the doctors and the statistician didn't know which group each child belonged to.
In the first group (called the control group), a 20% benzocaine gel was used, while the second group received clove oil. Before applying these substances, the area where the injection would happen was dried. Then, 0.3 mL of each pain-relief product was applied using a cotton roll, and it stayed there for 3 minutes.
A pediatric dentist administered the inferior alveolar nerve block (IANB), which was recorded on a mobile device (Mi 9, Xiaomi) to measure how much pain the participant was feeling by looking at the facial expressions.
What are the possible benefits and risks of participating?
Possible benefits are: Performing non-urgent dental treatment in the mandibular arch such as, pulpotomy, serial extraction, and pulpectomy.
Possible risk is: IANB will be painful if the topical anesthetic is not effective.
Where is the study run from?
Damascus University (Syria)
When is the study starting and how long is it expected to run for?
March 2022 to October 2022
Who is funding the study?
Damascus University (Syria)
Who is the main contact?
Dr Mawia Karkoutly, Mawiamaherkarkoutly@hotmail.com
Contact information
Public, Scientific, Principal Investigator
Mazzeh Highway
Damascus
-
Syria
0000-0003-0227-1560 | |
Phone | +963 992647528 |
mawia95.karkoutly@damascusuniversity.edu.sy |
Study information
Study design | Double‐blind randomized parallel‐group active-controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised parallel trial |
Study setting(s) | Dental clinic |
Study type | Treatment |
Participant information sheet | No participant information sheet available |
Scientific title | The effectiveness of clove oil as a topical anesthetic for healthy children during inferior alveolar nerve block: a randomized controlled trial |
Study objectives | The null hypothesis was that no statistically significant difference would be noted in efficacy of clove oil and benzocaine 20% gel in reducing pain from needle stick in children during the inferior alveolar nerve block. |
Ethics approval(s) |
Approved 09/05/2022, Ethical and Scientific Committee of Damascus University (Damascus University, Mazzeh Highway, Damascus, -, Syria; +963 992647528; dean.dent@damascusuniversity.edu.sy), ref: N1770 |
Health condition(s) or problem(s) studied | Dental pain |
Intervention | Children were randomly assigned into two groups in a ratio 1:1 using simple randomization method. The same number of children were randomly allocated to each intervention arm using randomization online software: https://www.randomizer.org. This was a double-blind trial where clinicians and statistician were blinded to which interventional arms children are assigned to. 20% benzocaine gel was applied for the first group (control group), and clove oil was applied for the second group. Mucosa drying was applied at the site of injection before application of the tested material, then 0,3 mL of each topical anesthetic was applied using a cotton roll for 3 minutes. IANB was performed by one pediatric dentist, and the child was videotaped using a mobile device (Mi 9, Xiaomi). The injection was made more posteriorly and slightly lower since the mandibular foramen is situated at a level lower in the pediatric patient. Therefore, the barrel of dental carpule syringe (Dental carpule syringe, Dental Laboratorio) was directed on the plane between the two primary molars on the opposite site of the arch, then a 27-gauge x 21 mm needle (Disposable Dental Needle, Shanghai Dochem Industries Co., Ltd.) was inserted, and 1.8 mL of 2% lidocaine with epinephrine 1:80,000 (2% Lidocaine HCL Injection, Huons Co., Ltd, Seongnam) was injected. |
Intervention type | Drug |
Pharmaceutical study type(s) | Not Applicable |
Phase | Not Applicable |
Drug / device / biological / vaccine name(s) | 20% benzocaine gel, clove oil, 2% lidocaine with epinephrine 1:80,000 |
Primary outcome measure | 1. The sound, eyes, and motor (SEM) scale was used to measure pain objectively during injection, and it evaluated by a blinded outcome assessor using the recorded video. 2. The Wong–Baker Faces Pain Rating Scale (WBFPS) was used to subjectively assess pain since children were asked to select the face that represented their pain level immediately after the IANB administration. |
Secondary outcome measures | There are no secondary outcome measures |
Overall study start date | 09/03/2022 |
Completion date | 20/10/2022 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Child |
Lower age limit | 7 Years |
Upper age limit | 11 Years |
Sex | Both |
Target number of participants | 60 |
Key inclusion criteria | 1. Healthy children. 2. Children aged 7-11 years. 3. Children with no previous dental experience. 4. Children requiring non-urgent dental treatment under IANB. |
Key exclusion criteria | 1. Children are allergic to any anesthetic agent used in this study. 2. Children with fascial space infections and/or dental abscesses. 3. Special health care needs children. 4. Children have odontophobia. |
Date of first enrolment | 20/06/2022 |
Date of final enrolment | 20/10/2022 |
Locations
Countries of recruitment
- Syria
Study participating centre
Damascus
-
Syria
Sponsor information
University/education
Mazzeh Highway
Damascus
-
Syria
Phone | +963 992647528 |
---|---|
info@damascusuniversity.edu.sy | |
Website | http://www.damascusuniversity.edu.sy |
https://ror.org/03m098d13 |
Funders
Funder type
University/education
Government organisation / Universities (academic only)
- Alternative name(s)
- University of Damascus, جَامِعَةُ دِمَشْقَ, DU
- Location
- Syria
Results and Publications
Intention to publish date | 31/12/2023 |
---|---|
Individual participant data (IPD) Intention to share | Yes |
IPD sharing plan summary | Available on request |
Publication and dissemination plan | Planned publication in a high-impact peer-reviewed journal. |
IPD sharing plan | The datasets generated during and/or analysed during the current study will be available upon request from Mawiamaherkarkoutly@hotmail.com |
Editorial Notes
10/11/2023: Internal review.
18/10/2023: Trial's existence confirmed by Damascus University.